The Chemours Overview
- Status
-
Public
- Employees
-
6,200
- Stock Symbol
-
CC
- Investments
-
4
- Share Price
-
$17.02
- (As of Wednesday Closing)
The Chemours General Information
Description
The Chemours Co is a global provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
Contact Information
Website
www.chemours.comCorporate Office
- 1007 Market Street
- P.O. Box 2047
- Wilmington, DE 19899
- United States
Corporate Office
- 1007 Market Street
- P.O. Box 2047
- Wilmington, DE 19899
- United States
The Chemours Timeline
The Chemours Stock Performance
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $17.02 | $16.79 | $15.10 - $32.70 | $2.54B | 149M | 1.42M | $0.76 |
The Chemours Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 6,876,568 | 8,060,743 | 7,229,100 | 8,517,966 |
| Revenue | 5,735,000 | 6,027,000 | 6,794,000 | 6,345,000 |
| EBITDA | 632,000 | 197,000 | 1,195,000 | 1,178,000 |
| Net Income | 115,000 | (238,000) | 578,000 | 608,000 |
| Total Assets | 7,249,000 | 8,251,000 | 7,640,000 | 7,550,000 |
| Total Debt | 4,236,000 | 4,299,000 | 3,880,000 | 3,987,000 |
The Chemours Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
The Chemours Comparisons
Industry
Financing
Details
000000
000000
The Chemours Competitors (44)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Kronos Worldwide | Corporation | Dallas, TX | 0000 | 00.000 | 000000000 00 | 00.000 |
| Kraton | Formerly PE-Backed | Houston, TX | 0000 | 00000 | 000000000 00 | |
| Arkema | Corporation | Colombes, France | 00000 | 00000 | 00000000000 | 00000 |
| Altana | Private Equity-Backed | Wesel, Germany | 0000 | 00.000 | 000000000 | 00.000 |
| Venator Materials | Formerly PE-Backed | Stockton-on-Tees, United Kingdom | 0000 | 00000 | 00000000. 00 | 00000 |
The Chemours Patents
The Chemours Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-9840685-B2 | Ternary compositions of methyl perfluoroheptene ethers and trans-1,2-dichloroethylene, and uses thereof | Active | 08-May-2015 | 0000000000 | 0 |
| US-20160326468-A1 | Ternary compositions of methyl perfluoroheptene ethers and trans-1,2-dichloroethylene, and uses thereof | Active | 08-May-2015 | 0000000000 | 0 |
| US-20150218386-A1 | Treatment of tailings streams | Active | 29-Oct-2008 | C04B28/24 | 0 |
The Chemours Executive Team (33)
| Name | Title | Board Seat |
|---|---|---|
| Denise Dignam | Chief Executive Officer & Board Member | |
| Diane Picho | President | |
| Matthew Abbott | Chief Financial Officer, Finance & Executive | |
| Shane Hostetter | Chief Financial Officer & Senior Vice President | |
| Camela Wisel | Chief Accounting Officer, Accounting & Controller, Finance |
The Chemours Board Members (16)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000000 00000 | Self | Board Member | 000 0000 |
| 000000 000000000 | Self | Board Member | 000 0000 |
| 0000 0000000 | Self | Chairman & Board Member | 000 0000 |
| 000000 000000 | The Chemours | Chief Executive Officer & Board Member | 000 0000 |
| 0000 0000 | Self | Board Member | 000 0000 |
The Chemours Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
The Chemours Investments & Acquisitions (4)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| THE Mobility F.C. Membranes Company | 10-Oct-2022 | 00000 0000 | Industrial Chemicals | 000000 00 | |
| Versogen | 21-Apr-2022 | 00000 0000 | 000.00 | Alternative Energy Equipment | |
| Southern Ionics Minerals | 01-Aug-2019 | 0000000000 | 0000 | Multi-line Mining | |
| ICOR International | 03-Apr-2018 | Merger/Acquisition | 0000 | Other Commercial Products | 00000 000 |
The Chemours ESG
Risk Overview
Risk Rating
Updated June, 18, 2024
25.54 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.0
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 16,009
Rank
Percentile
Chemicals
Industry
00 of 606
Rank
Percentile
Diversified Chemicals
Subindustry
00 of 63
Rank
Percentile
The Chemours FAQs
-
Who is the CEO of The Chemours?
Denise Dignam is the CEO of The Chemours.
-
Where is The Chemours headquartered?
The Chemours is headquartered in Wilmington, DE.
-
What is the size of The Chemours?
The Chemours has 6,200 total employees.
-
What industry is The Chemours in?
The Chemours’s primary industry is Industrial Chemicals.
-
Is The Chemours a private or public company?
The Chemours is a Public company.
-
What is The Chemours’s stock symbol?
The ticker symbol for The Chemours is CC.
-
What is the current stock price of The Chemours?
As of 11-Sep-2024 the stock price of The Chemours is $17.02.
-
What is the current market cap of The Chemours?
The current market capitalization of The Chemours is $2.54B.
-
What is The Chemours’s current revenue?
The trailing twelve month revenue for The Chemours is $5.74B.
-
Who are The Chemours’s competitors?
Kronos Worldwide, Kraton, Arkema, Altana, and Venator Materials are some of the 44 competitors of The Chemours.
-
What is The Chemours’s annual earnings per share (EPS)?
The Chemours’s EPS for 12 months was $0.76.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
